In the News

Researchers have created news prediction models that may improve the personalised treatment of lymph nodes in patients with breast cancer, according to a study published in Clinical Cancer Research. “It is well known that knowledge of the spread of breast cancer to the axillary lymph nodes...
Selective mammography screening can provide potentially lifesaving early detection of breast cancer in men who are at high risk for the disease, according to a study published in Radiology. There are currently no formal screening guidelines for men in groups at high risk for breast cancer, such as...
The US Food and Drug Administration (FDA) is warning that palbociclib (Ibrance), ribociclib (Kisqali), and abemaciclib (Verzenio) used to treat some patients with advanced breast cancers may cause rare but severe inflammation of the lungs. The agency has approved new warnings about this risk to...
The presence of mental health comorbidity in older breast cancer survivors significantly increases the risk of opioid use and mortality, which highlights the need for better management of comorbid mental health conditions, according to a study published in the Journal of Oncology Practice. “The...
Researchers have developed a genomically-based model that can optimise and personalise a radiation dose to match an individual patient’s needs. Previously, Javier Torres-Roca, MD, Moffitt Cancer Center, Tampa, Florida, and colleagues developed and validated a radiation sensitivity index (RSI) to...

Conference Reports

By Walter Alexander

CHICAGO -- June 3, 2019 -- Compared with endocrine therapy alone, ribociclib plus endocrine therapy results in a statistically significant longer overall survival in patients with hormone receptor positive (HR+) / human epidermal receptor 2-negative (HER2-) advanced...

By Jenny Powers

BERLIN -- May 6, 2019 -- Contrary to expectations, intermittent treatment for patients with advanced human epidermal growth factor receptor 2 (HER2)-negative breast cancer did not improve quality of life (QOL) compared with patients on a continuous schedule, according to a...

By Jenny Powers

BERLIN -- May 6, 2019 -- Adding everolimus to aromatase inhibitor (AI) maintenance therapy after chemo provided nearly 3 months of additional progression-free survival (PFS) for patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-...

By Jenny Powers

BERLIN -- May 6, 2019 -- Tumour size and the presence of node involvement upon the diagnosis of early-stage breast cancer signalled women at risk of cancer recurrence, even after they achieved pathological complete response (pCR) with therapy, researchers reported here at...

By Jenny Powers

BERLIN -- May 6, 2019 -- More aggressive types of breast cancers, such as human epidermal growth factor receptor 2 (HER2)-positive and triple-negative tumours, are more frequently diagnosed in very young women aged 35 years and younger, according to a study presented here...

Recently Published

Clinical Cancer Research
Yirui Gui, Adriana Aguilar-Mahecha, Urszula Krzemien, Abdel Hosein, Marguerite Buchanan, Josiane Lafleur, Michael N Pollak, Cristiano Ferrario, Mark Basik
Breast Journal
Vivienne Blackhall, Martina Bugelli, Nick Abbott, Russell Mullen
Breast Journal
Devon Livingston-Rosanoff, Bret Hanlon, Nicholas Marka, Kara Vande Walle, Trista Stankowski-Drengler, Jessica Schumacher, Caprice C Greenberg, Heather Neuman, Lee G Wilke
Breast Journal
Irene Valente, Giulia Tringali, Eugenia Marta Martella, Lara Pallavera, Cecilia D'Aloia
Clinical Cancer Research
Xuexin He, Jiali Ji, Mei Tian, Francisco J Esteva, Gabriel N Hortobagyi, Sai-Ching J Yeung

Full-Text Articles

Breast Cancer Research
Doris Leithner, Joao V Horvat, Maria Adele Marino, Blanca Bernard-Davila, Maxine S Jochelson, R Elena Ochoa-Albiztegui, Danny F Martinez, Elizabeth A Morris, Sunitha Thakur, Katja Pinker
BMC Cancer
Kai Joachim Borm, Christine Schönknecht, Andrea Nestler, Markus Oechsner, Birgit Waschulzik, Stephanie Elisabeth Combs, Stefan Münch, Markus Niemeyer, Marciana Nona Duma
BMC Cancer
Sabine Schmid, Dirk Klingbiel, Stefan Aebi, Aron Goldhirsch, Christoph Mamot, Elisabetta Munzone, Franco Nolè, Christian Oehlschlegel, Olivia Pagani, Bernhard Pestalozzi, Christoph Rochlitz, Beat Thürlimann, Roger von Moos, Patrik Weder, Khalil Zaman, Thomas Ruhstaller
Asian Journal of Surgery
Azmi Lale, Mesut Yur, Halit Özgül, Ertuğrul Gazi Alkurt, Nilgün Yıldırım, Erhan Aygen, Abdullah Bahadır Öz, Türkmen Bahadır Arıkan